Increasing oxidative stress with progressive hyperlipidemia in human: relation between malondialdehyde and atherogenic Index
Kimmoun A, Munagamage G, Dessalles N, Gerard A, Feillet F, Levy B
Synthetic therapeutic peptides: science and market
This article begins with an overview of basic pathological mechanisms and offers a comprehensive overview of relevant therapeutic approaches and future development directions, aiming to facilitate the transition of the field from traditional generalized therapies to personalized precision medicine and to bridge the long-standing gap between basic research and clinical practice
The gap between doing it right and doing it wrong comes down to three things most guides never mention: baseline nutrient status, the interaction between lipotropic compounds and GLP-1 receptor agonists, and the mistake of treating Lipo C as a standalone intervention rather than a metabolic support tool